Brokerage Nomura upheld a neutral rating on Persistent Systems, while Investec continues to advocate a buy stance on Natco Pharma and has initiated a buy recommendation on Entero Healthcare. Conversely, CLSA has downgraded RIL to an outperform rating.
Spandana Sphoorty to raise Rs 400 crore via rights issue for FY26 plans
Spandana Sphoorty Financial will raise up to Rs 400 crore through a rights issue as part of its Rs 750 crore FY26 equity plan. Board